Zacks Investment AwarenessThe 21st Century Cures Act: The First 90 Days and ReplicelMar 9, 2017Mar 9, 2017
Zacks Investment AwarenessBioVie, Inc. To Benefit From Big Pharma Focus On NASHMar 6, 2017Mar 6, 2017
Zacks Investment AwarenessBig changes at the FDA?Biotech Companies hope “Safety” is the new approval standard.Feb 27, 2017Feb 27, 2017